Cancer agency OK'd faulty $11M grant
(AP)—Texas' embattled $3 billion cancer-fighting agency approved an $11 million grant to a biomedical company even though the proposal wasn't reviewed.
Nov 29, 2012
Archive: 29/11/2012
New patient-friendly way to make stem cells for fight against heart disease
funded by the British Heart Foundation (BHF), Medical Research Council (MRC) and Wellcome Trust – have today published a patient-friendly and efficient way to make stem cells out of blood, increasing the hope that scientists ...
Nov 29, 2012
Understanding of the mechanisms of drug resistance to dual-agent chemotherapy in ovarian cancer
More than half of all patients with ovarian cancer experience recurrent disease and will eventually fail to respond to chemotherapy. The failure of chemotherapy is usually due to the development of resistance to the two main ...
Nov 29, 2012
Cometriq approved for rare thyroid cancer
(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.
Nov 29, 2012
S.Africa seals record deal for low-cost ARVs: minister
South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.
Nov 29, 2012
HCMV researchers utilize novel techniques to show preferential repair of the viral genome
A new study about Human Cytomegalovirus (HCMV), a leading cause of birth defects, reveals how the virus co-opts cells' abilities to repair themselves. In the paper published on November 29 in the Open Access journal PLOS ...
Nov 29, 2012
Study provides first direct evidence linking TB infection in cattle and local badger populations
Transmission of tuberculosis between cattle and badgers has been tracked at a local scale for the first time, using a combination of bacterial whole genome DNA sequencing and mathematical modelling. The findings highlight ...
Nov 29, 2012
Genome-scale study identifies hundreds of potential drug targets for Huntington's disease
Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) ...
Nov 29, 2012
Sneak peek at early course of bladder infection caused by widespread, understudied parasite
Using standard tools of the molecular-biology trade and a new, much-improved animal model of a prevalent but poorly understood tropical parasitic disease called urogenital schistosomiasis, Stanford University School of Medicine ...
Nov 29, 2012
